logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
01/05/2025
AppLovin's pre-market plunge in US stocks has fallen by more than 10%, reaching $259.97.
Latest
4 m ago
Keefe, Bruyette & Woods: Maintains United Community Banks (UCB.US) rating, adjusted from outperform to market perform, with a target price changed from $35.00 to $32.00.
5 m ago
Royal Bank of Canada: Maintains Shift4 Payments (FOUR.US) rating, adjusting from outperforming the market to outperforming the market rating, with a target price adjustment from $154.00 to $127.00.
6 m ago
Rich Country Bank: Maintains rating on Crown Holdings (CCK.US) at Hold, adjusted from Hold to Hold, Target price adjusted from $89.00 to $101.00.
7 m ago
Bank of America: Maintains S&P Global (SPGI.US) rating, adjusted from neutral to buy rating, target price adjusted from $607.00 to $627.00.
7 m ago
According to the AI bulletin of Every Economic, Huatai Securities released a research report on April 30, giving a buy rating to KSC Bio (688046.SH). The reasons for the rating mainly include: 1) domestic new production capacity is close to full production, continuously optimizing the shipping system to reduce costs; 2) rapid growth of overseas business, increasing market expansion in overseas markets; 3) maintaining high-intensity investment in research and development, enriching the category of experimental animal models. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.